Cynomolgus Monkey (Macaca fascicularis) Interleukin-10 (IL-10) is a key anti-inflammatory cytokine produced by regulatory T cells (Tregs), Th2 cells, macrophages, dendritic cells, and certain B-cell populations, where it plays a central role in limiting excessive immune activation and maintaining immune homeostasis. Highly homologous to human IL-10, cynomolgus IL-10 signals through the IL-10 receptor complex (IL-10R1/IL-10R2), activating JAK/STAT3 pathways that suppress pro-inflammatory cytokine production (including IL-1β, TNF-α, and IFN-γ), reduce antigen presentation, and downregulate Th1-type cell-mediated responses. In nonhuman primate models, IL-10 is critically involved in modulating immune responses during infections such as dengue virus, influenza, SARS-CoV-2, simian immunodeficiency virus (SIV), tuberculosis, and bacterial sepsis, where elevated IL-10 levels can help prevent immunopathology but may also contribute to immune suppression and pathogen persistence. The IL-10/pro-inflammatory cytokine balance is frequently assessed in vaccine studies, immunotoxicology evaluations, and biologic safety testing. Because cynomolgus monkeys are widely used in preclinical research due to their close genetic and immunologic similarity to humans, characterization of IL-10 is essential for understanding immune regulation, cytokine network dynamics, and therapeutic modulation of inflammatory responses, providing critical translational insight into human infectious, autoimmune, and inflammatory diseases.